Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Glioblastoma 4Glioma 3Brain Neoplasms 3Neuroblastoma 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Spinal Cord Neoplasms 1Sarcoma 1Paraganglioma, Extra-Adrenal 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Oligodendroglioma 1Neurofibroma 1Neoplasms 1Meningioma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Medullary 1

Interventions

Filgrastim 14Carboplatin 11Peripheral Blood Stem Cell Transplantation 9Ifosfamide 9Etoposide 8Flow Cytometry 5Thiotepa 4Therapeutics 4Paclitaxel 4Cyclophosphamide 4Cisplatin 4pegfilgrastim 3Temozolomide 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Melphalan 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3Busulfan 3sargramostim 2liposomal amphotericin B 2ixabepilone 2etoposide phosphate 2aldesleukin 2Topotecan 2Radiotherapy 2Ondansetron 2Methylprednisolone 2Magnetic Resonance Spectroscopy 2Itraconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Restraint, Physical × CNS × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡